VIVUS (VVUS) Reports In-Line Q4 EPS

VIVUS (NASDAQ: VVUS) reported Q4 EPS of ($0.25), in-line with the analyst estimate of ($0.25). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $20 million.

Of the total revenue for the current quarter, net product revenue was $12.7 million from sales of Qsymia, compared to $7.7 million for the fourth quarter of 2013. In addition, under our commercialization

For earnings history and earnings-related data on VIVUS (VVUS) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Renasant Corp. (RNST) Tops Q1 EPS by 3c
• WesBanco (WSBC) Tops Q1 EPS by 1c